E-LIB Suche - Ergebnisse für: Ottensmeier, C. H.

1

155P BNT113 + pembrolizumab as first-line treatment in pati..:

Klinghammer, K. ; Saba, N.F. ; Castelluci, E....
Immuno-Oncology and Technology. 16 (2022) - p. 100267 , 2022

Link: https://doi.org/10.1016/..

2

Adjuvant bevacizumab for melanoma patients at high risk of ..:

Corrie, P.G. ; Marshall, A. ; Nathan, P.D....
Annals of Oncology. 30 (2019) 12 - p. 2013-2014 , 2019

Link: https://doi.org/10.1093/..

3

OS2.2Highly personalized peptide vaccination for patients w..:

Dietrich, P ; Wick, W ; Hilf, N...
Neuro-Oncology. 20 (2018) suppl_3 - p. iii219-iii219 , 2018

Link: https://doi.org/10.1093/..

4

PO-516 E6/E7 RNA(LIP): a novel liposomal RNA vaccine for tr..:

Grunwitz, C. ; Jahndel, V. ; Braun, J....
ESMO Open. 3 (2018) - p. A224-A225 , 2018

Link: https://doi.org/10.1136/..

5

Adjuvant bevacizumab for melanoma patients at high risk of ..:

Corrie, P.G. ; Marshall, A. ; Nathan, P.D....
Annals of Oncology. 29 (2018) 8 - p. 1843-1852 , 2018

Link: https://doi.org/10.1093/..

6

Assessment of neuronal autoantibodies in patients with smal..:

Hardy-Werbin, M. ; Arpí, O. ; Taus, A....
OncoImmunology. 7 (2017) 2 - p. , 2017

Link: https://doi.org/10.1080/..

7

The effect of neoadjuvant chemotherapy on physical fitness ..:

Jack, S. ; West, M.A. ; Raw, D....
European Journal of Surgical Oncology (EJSO). 40 (2014) 10 - p. 1313-1320 , 2014

Link: https://doi.org/10.1016/..

8

The adaptive immune response to colorectal cancer: From the..:

Curtis, N.J. ; Primrose, J.N. ; Thomas, G.J...
European Journal of Surgical Oncology (EJSO). 38 (2012) 10 - p. 889-896 , 2012

Link: https://doi.org/10.1016/..

9

119 Phase I dose finding study of irinotecan in combination..:

Nolan, L. ; Bradbury, J.A. ; Muthuramalingam, S....
Lung Cancer. 71 (2011) - p. S41 , 2011

Link: https://doi.org/10.1016/..

10

Ig gene diversification and selection in follicular lymphom..:

Zuckerman, N. S. ; McCann, K. J. ; Ottensmeier, C. H....
International Immunology. 22 (2010) 11 - p. 875-887 , 2010

Link: https://doi.org/10.1093/..

11

Systematic review and meta-analysis of immunohistochemical ..:

McCormick Matthews, L H ; Noble, F ; Tod, J...
British Journal of Cancer. 113 (2015) 1 - p. 107-118 , 2015

Link: https://doi.org/10.1038/..

12

3353 Seropositivity to tumour antigens as a potential new b..:

Clark, L. ; Hepburne-Scott, H. ; Ottensmeier, C....
European Journal of Cancer. 51 (2015) - p. S686 , 2015

Link: https://doi.org/10.1016/..

13

TIME, a Phase 2b/3 Study Evaluating TG4010 in Combination W..:

Quoix, E. ; Losonczy, G. ; Forget, F....
International Journal of Radiation Oncology*Biology*Physics. 90 (2014) 5 - p. S35 , 2014

Link: https://doi.org/10.1016/..

14

Afatinib use in non-small cell lung cancer previously sensi..:

Khan, F. ; Ottensmeier, C. ; Popat, S....
European Journal of Cancer. 50 (2014) 10 - p. 1717-1721 , 2014

Link: https://doi.org/10.1016/..

15

106. Initial UK experience of melphalan percutaneous hepati..:

Stedman, B. ; Wilson, I. ; El Berm, H....
European Journal of Surgical Oncology (EJSO). 40 (2014) 11 - p. S50 , 2014

Link: https://doi.org/10.1016/..